What We Do

Eyevance is focused on developing innovative and impactful therapies that address the unmet needs of patients and their ophthalmic healthcare providers.

Eyevance-Therapeutic-Areas-Chart
  • Post Op Inflammation
  • Dry Eye
  • Blepharitis
  • Conjunctivitis (Allergic, Viral, Bacterial)
  • Retina – AMD, DME, RVO
  • Uveitis, Sustained Drug Delivery
  • Sustained Drug Delivery
  • IOP Lowering therapies
  • First of its kind
  • Unmet medical need with no present therapeutic option
  • Unique biologic/small molecule profile

Target
Therapeutic Areas

Anterior Segment

  • Post Op Inflammation
  • Dry Eye
  • Blepharitis
  • Conjunctivitis (Allergic, Viral, Bacterial)

Posterior Segment

  • Retina – AMD, DME, RVO
  • Uveitis, Sustained Drug Delivery

Glaucoma

  • Sustained Drug Delivery
  • IOP Lowering therapies

Rare/Orphan

  • First of its kind
  • Unmet medical need with no FDA-approved
    therapeutic alternatives
  • Unique biologic/small molecule profile
Contact Eyevance

Our Mission

Eyevance Pharmaceuticals’ mission is to develop and commercialize innovative and impactful ophthalmic products to enable optimal vision and better quality of life for all patients.

Connect With Eyevance